Missed opportunities for HIV pre-exposure prophylaxis during a rapid scale-up program at Sydney Sexual Health Centre
David Atefi A C , Ruthy McIver A and Christopher Bourne A BA Sydney Sexual Health Centre, Nightingale Wing, Sydney/Sydney Eye Hospital, 8 Macquarie Street, Sydney, NSW 2000, Australia.
B The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
C Corresponding author. Email: david.atefi@health.nsw.gov.au
Sexual Health 16(6) 591-592 https://doi.org/10.1071/SH19032
Submitted: 15 February 2019 Accepted: 22 April 2019 Published: 23 October 2019
Abstract
We aimed to estimate HIV pre-exposure prophylaxis (PrEP) uptake and missed opportunities for PrEP through a retrospective review of medical records of clients at high risk of HIV attending the Sydney Sexual Health Centre. Most clients (69%) were taking PrEP, and 7% of those eligible for PrEP were classified as a missed opportunity for PrEP. Although missed opportunities were uncommon, PrEP discussions should be a standard component of care for all clients at risk of HIV acquisition.
Additional keywords: men who have sex with men, prevention.
References
[1] New South Wales (NSW) Ministry of Health. NSW HIV strategy 2016–2020. Sydney: NSW Ministry of Health; 2015.[2] Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV 2018; 5 e629–37.
| Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 30343026PubMed |
[3] New South Wales (NSW) Ministry of Health. NSW HIV strategy 2016–2020 data report quarter 3. Sydney: NSW Ministry of Health; 2018.
[4] Wright E, Grulich A, Roy K, Boyd M, Cornelisse V, Russell D, et al Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018. J Virus Erad 2017; 3 168–84.
| 28758027PubMed |
